Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Anti fibrin monoclonal antibody 3B6/22 Tc 99m

Drug Profile

Anti fibrin monoclonal antibody 3B6/22 Tc 99m

Alternative Names: Tc 99m 3B6/22; Tc 99m anti-fibrin monoclonal antibody 3B6/22; ThromboView

Latest Information Update: 16 Mar 2018

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Agenix
  • Class Imaging agents; Monoclonal antibodies; Organotechnetium compounds; Radiopharmaceutical diagnostics; Radiopharmaceuticals; Technetium compounds
  • Mechanism of Action Radionuclide imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes
  • Available For Licensing Yes - Deep vein thrombosis; Pulmonary embolism

Highest Development Phases

  • Discontinued Deep vein thrombosis; Pulmonary embolism

Most Recent Events

  • 07 Dec 2015 Discontinued - Phase-I for Pulmonary embolism (Diagnosis) in Australia (IV)
  • 07 Dec 2015 Discontinued - Phase-II for Deep vein thrombosis (Diagnosis) in USA and Canada (IV)
  • 07 Dec 2015 Discontinued - Phase-II for Pulmonary embolism (Diagnosis) in USA and Canada (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top